
  
    
      
        Background_NNP
        One_CD of_IN the_DT major_JJ cellular_JJ serine_NN /_NN threonine_NN protein_NN
        phosphatases_NNS is_VBZ protein_NN phosphatase_NN type_NN 1_CD (_( PP_NNP 1_LS )_) [_NN 1_CD ]_NN ._. An_DT
        abundant_JJ enzyme_NN expressed_VBD in_IN all_DT cells_NNS ,_, complex_JJ regulation_NN
        of_IN PP_NNP 1_CD is_VBZ thought_VBN to_TO be_VB essential_JJ for_IN proper_JJ temporal_JJ and_CC
        spatial_NN regulation_NN of_IN PP_NNP 1_CD catalytic_JJ activity_NN towards_IN
        individual_JJ substrates_NNS [_NN 2_CD ]_NN ._. Three_CD different_JJ isotypes_NNS of_IN
        the_DT catalytic_JJ subunit_NN ,_, designated_VBN PP_NNP 1_CD α_NN ,_, PP_NNP 1_CD δ_NN ,_, and_CC PP_NNP 1_CD γ_NN 1_CD ,_,
        are_VBP expressed_VBN in_IN many_JJ different_JJ cell_NN types_NNS [_NN 3_CD ]_NN ._. Studies_NNPS
        employing_VBG many_JJ eukaryotic_JJ systems_NNS all_DT point_NN to_TO a_DT crucial_JJ
        role_NN for_IN PP_NNP 1_CD activity_NN in_IN controlling_VBG cell_NN cycle_NN
        progression_NN ,_, and_CC an_DT absolute_JJ requirement_NN of_IN this_DT activity_NN
        for_IN mitotic_JJ exit_NN [_NN 4_CD 5_CD 6_CD 7_CD ]_NN ._. There_EX is_VBZ also_RB evidence_NN to_TO
        suggest_VB that_DT phosphorylation_NN of_IN PP_NNP 1_CD and_CC its_PRP$ associated_VBN
        proteins_NNS by_IN the_DT cyclin-dependent_JJ kinases_NNS may_MD regulate_VB PP_NNP 1_CD
        activity_NN in_IN a_DT cell_NN cycle_NN stage-dependent_JJ manner_NN [_NN 8_CD 9_CD 10_CD ]_NN
        ._. Hence_RB ,_, current_JJ efforts_NNS are_VBP directed_VBN towards_IN
        identification_NN of_IN cell_NN cycle-dependent_JJ substrates_NNS for_IN PP_NNP 1_CD ,_,
        and_CC how_WRB regulation_NN of_IN PP_NNP 1_CD activity_NN towards_IN these_DT substrates_NNS
        controls_VBZ the_DT cell_NN division_NN cycle_NN ._.
        One_CD physiological_JJ substrate_NN for_IN PP_NNP 1_CD appears_VBZ to_TO be_VB the_DT
        product_NN of_IN the_DT retinoblastoma_NN susceptibility_NN gene_NN ,_, pRB_NN [_NN 11_CD
        12_CD 13_CD ]_NN ,_, a_DT demonstrated_VBN tumor_NN suppressor_NN ._. The_DT cell_NN growth_NN
        and_CC tumor_NN suppressive_JJ activity_NN of_IN pRB_NN is_VBZ regulated_VBN by_IN its_PRP$
        phosphorylation_NN state_NN ._. pRB_NN phosphorylation_NN varies_VBZ as_IN a_DT
        function_NN of_IN cell_NN cycle_NN phase_NN ;_: during_IN G_NNP 
        1_CD the_DT hypophosphorylated_JJ form_NN
        predominates_NNS ,_, while_IN the_DT hyperphosphorylated_JJ form_NN
        accumulates_NNS during_IN S_NNP ,_, G_NNP 
        2_CD and_CC M_NNP phase_NN [_NN 14_CD 15_CD 16_CD ]_NN ._. It_PRP is_VBZ this_DT
        hypophosphorylated_JJ form_NN of_IN pRB_NN present_JJ during_IN early_JJ and_CC mid_JJ
        G_NNP 
        1_CD which_WDT functions_NNS to_TO modify_VB gene_NN
        expression_NN ._. This_DT is_VBZ achieved_VBN by_IN complexing_VBG with_IN
        transcription_NN factors_NNS resulting_VBG in_IN repression_NN [_NN 17_CD ]_NN or_CC
        stimulation_NN [_NN 18_CD ]_NN of_IN transcription_NN ._. Under_IN conditions_NNS
        favoring_VBG proliferation_NN ,_, the_DT phosphorylation_NN of_IN pRB_NN via_IN
        cyclin-dependent_JJ kinases_NNS (_( CDKs_NNP )_) in_IN mid-to-late_JJ G_NNP 
        1_CD phase_NN results_NNS in_IN liberation_NN of_IN E_NNP 2_CD F_NN and_CC
        other_JJ pRB-bound_JJ transcription_NN factors_NNS ,_, which_WDT then_RB activate_VBP
        the_DT transcription_NN of_IN S-_NNP phase_NN genes_NNS [_NN 19_CD ]_NN ._. In_IN late_JJ M_NNP
        phase_NN ,_, pRB_NN returns_NNS to_TO its_PRP$ growth_NN suppressive_JJ ,_,
        hypophosphorylated_JJ form_NN due_JJ to_TO the_DT action_NN of_IN a_DT pRB-directed_JJ
        protein_NN phosphatase_NN belonging_VBG to_TO the_DT type_NN 1_CD class_NN of_IN
        serine_NN /_NN threonine_NN protein_NN phosphatases_NNS [_NN 11_CD 20_CD 21_CD ]_NN ._.
        Of_IN critical_JJ importance_NN is_VBZ the_DT question_NN of_IN the_DT 
        in_IN vivo_NN effect_NN of_IN PP_NNP 1_CD activity_NN on_IN pRB_NN
        and_CC growth_NN regulation_NN ._. To_TO date_NN ,_, several_JJ techniques_NNS have_VBP
        been_VBN employed_VBN in_IN this_DT regard_NN to_TO demonstrate_VB PP_NNP 1_CD actions_NNS in_IN
        intact_JJ cells_NNS ._. Berndt_NNP et_CC ._. al_NN ._. [_NN 22_CD ]_NN used_VBD electroporation_NN to_TO
        introduce_VB PP_NNP 1_CD protein_NN into_IN tissue_NN culture_NN cells_NNS having_VBG
        noted_VBN that_IN previous_JJ genetic_JJ attempts_NNS to_TO accomplish_VB
        overexpression_NN were_VBD not_RB readily_RB accomplished_VBN ._. Using_VBG this_DT
        technique_NN ,_, they_PRP showed_VBD a_DT G_NNP 1_CD block_VB by_IN PP_NNP 1_CD that_WDT was_VBD dependent_JJ
        upon_IN the_DT presence_NN of_IN pRB_NN ._. In_IN another_DT report_NN ,_,
        micro-injection_JJ of_IN PP_NNP 1_CD decreased_VBD extractability_NN of_IN pRB_NN from_IN
        nuclei_NN ,_, presumably_RB by_IN increasing_VBG dephosphorylation_NN and_CC
        increasing_VBG association_NN with_IN nuclear_JJ proteins_NNS thereby_RB
        playing_VBG a_DT role_NN in_IN G_NNP 1_CD /_NN S_NNP transition_NN inhibition_NN [_NN 13_CD ]_NN ._.
        Micro-injection_NNP of_IN antibodies_NNS to_TO the_DT PP_NNP 1_CD catalytic_JJ subunit_NN
        has_VBZ been_VBN shown_VBN to_TO block_VB cells_NNS in_IN metaphase_NN [_NN 23_CD ]_NN ._. Since_IN
        this_DT is_VBZ the_DT time_NN during_IN mitosis_NNS when_WRB pRB_NN is_VBZ normally_RB
        dephosphorylated_JJ [_NN 11_CD 24_CD ]_NN ,_, it_PRP is_VBZ tempting_JJ to_TO speculate_VB
        that_DT prevention_NN of_IN pRB_NN dephosphorylation_NN by_IN inhibiting_VBG PP_NNP 1_CD
        activity_NN impedes_VBZ an_DT orderly_JJ progression_NN through_IN mitosis_NNS ,_,
        perhaps_RB contributing_VBG towards_IN a_DT transformed_VBN phenotype_NN ._.
        Here_RB ,_, using_VBG the_DT tetracycline_NN induction_NN system_NN [_NN 25_CD ]_NN ,_,
        we_PRP developed_VBD an_DT inducible_JJ PP_NNP 1_CD expression_NN system_NN to_TO
        investigate_VB the_DT regulation_NN of_IN PP_NNP 1_CD activity_NN ._. We_PRP view_VBP this_DT as_IN
        a_DT first_JJ step_NN towards_IN addressing_VBG the_DT question_NN of_IN the_DT 
        in_IN vivo_NN effect_NN of_IN PP_NNP 1_CD activity_NN on_IN pRB_NN
        and_CC growth_NN regulation_NN ._. Our_PRP$ results_NNS support_VBP the_DT notion_NN that_WDT
        induced_VBD PP_NNP 1_CD α_NN protein_NN functions_NNS identically_RB to_TO endogenous_JJ
        PP_NNP 1_CD α_NN with_IN respect_NN to_TO non-catalytic_JJ subunit_NN binding_JJ and_CC
        activity_NN towards_IN phosphorylase_NN 
        a_DT and_NN the_DT tumor_NN suppressor_NN pRB_NN ._.
        Localization_NNP of_IN this_DT protein_NN to_TO the_DT nucleus_NN also_RB mirrors_VBZ
        that_IN of_IN endogenous_JJ PP_NNP 1_CD α_NN 
        in_IN vivo_NN ._. When_WRB using_VBG this_DT system_NN to_TO
        forcibly_RB overexpress_NNS 6_CD His-_NNP HA-PP_NNP 1_CD α_NN ,_, there_EX is_VBZ a_DT concomitant_NN
        decrease_NN in_IN endogenous_JJ PP_NNP 1_CD α_NN levels_NNS ,_, suggesting_VBG the_DT
        existence_NN of_IN an_DT autoregulatory_NN mechanism_NN by_IN which_WDT PP_NNP 1_CD α_NN
        protein_NN levels_NNS remain_VBP constant_JJ ._. RT-PCR_NNP analyses_NNS of_IN isolated_VBN
        polysome_NN fractions_NNS supports_VBZ the_DT notion_NN that_IN this_DT putative_JJ
        autoregulatory_NN mechanism_NN is_VBZ exerted_VBN ,_, at_IN least_JJS in_IN part_NN ,_, at_IN
        the_DT translational_NN level_NN ._.
      
      
        Results_NNS and_CC Discussion_NNP
        
          Induction_NNP of_IN 6_CD His-_NNP HA-PP_NNP 1_CD in_IN LLW_NNP 02_CD F_NN cells_NNS
          Figure_NN 1_CD shows_VBZ construct_VB of_IN the_DT tetracycline-inducible_JJ
          plasmid_NN used_VBN to_TO express_VB 6_CD His-_NNP HA-PP_NNP 1_CD α_NN ._. As_IN shown_VBN in_IN Figure_NN
          2_CD A_DT ,_, 24_CD hr_NN incubation_NN with_IN doxycycline_NN in_IN the_DT medium_NN has_VBZ
          no_DT appreciable_JJ effect_NN on_IN endogenous_JJ PP_NNP 1_CD α_NN protein_NN
          expression_NN in_IN the_DT untransfected_JJ parent_NN cell_NN line_NN (_( UMUC_NNP 3_LS )_)
          or_CC a_DT cell_NN line_NN transfected_JJ with_IN the_DT reverse_JJ tetracycline_NN
          transactivator_NN plasmid_NN pUHD_NN 172_CD -_: 1_CD neo_NN only_RB (_( LLWO_NNP 1_LS )_) ._. A_DT time_NN
          course_NN of_IN induction_NN by_IN doxycycline_NN was_VBD then_RB carried_VBN out_IN
          in_IN stable_JJ clone_NN LLWO_NNP 2_CD F_NN ._. Harvested_NNP at_IN various_JJ time_NN
          intervals_NNS ,_, whole-cell_JJ lysates_NNS were_VBD prepared_VBN and_CC the_DT
          proteins_NNS were_VBD separated_VBN by_IN SDS-PAGE_NNP for_IN western_JJ blotting_VBG
          using_VBG antibody_NN to_TO the_DT hemagglutinin_NN tag_NN ._. As_IN shown_VBN in_IN
          Figure_NN 2_CD B_NNP ,_, a_DT protein_NN with_IN the_DT anticipated_VBN molecular_JJ
          weight_NN of_IN 40_CD kDa_NN was_VBD detected_VBN ._. A_DT clear_JJ differential_NN of_IN
          expression_NN of_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN (_( indicated_VBD at_IN the_DT left_VBN of_IN the_DT
          panel_NN )_) was_VBD observed_VBN at_IN 1_CD ._. 5_CD hours_NNS after_IN addition_NN of_IN
          doxycycline_NN ,_, which_WDT became_VBD more_RBR pronounced_JJ at_IN later_RB time_NN
          points_NNS ._. The_DT doxycycline-independent_JJ increase_NN in_IN
          6_CD His-_NNP HA-PP_NNP 1_CD α_NN is_VBZ attributed_VBN to_TO background_NN expression_NN when_WRB
          using_VBG this_DT system_NN [_NN 25_CD ]_NN ._. As_IN predicted_VBD for_IN a_DT protein_NN
          under_IN the_DT control_NN of_IN the_DT doxycycline-inducible_JJ promoter_NN ,_,
          the_DT abundance_NN of_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN decreases_NNS in_IN the_DT absence_NN of_IN
          the_DT inducer_NN over_IN time_NN (_( Figure_NN 2_CD C_NNP )_) ._. Subsequent_JJ time_NN course_NN
          experiments_NNS revealed_VBD peak_NN abundance_NN occurring_VBG between_IN 16_CD
          and_CC 24_CD hr_NN ,_, and_CC remaining_VBG constant_JJ thereafter_RB for_IN at_IN least_JJS
          72_CD hr_NN ,_, at_IN which_WDT time_NN the_DT experiment_NN was_VBD terminated_VBN ._. As_IN
          such_JJ ,_, we_PRP have_VBP chosen_VBN the_DT 24_CD hr_NN induction_NN time_NN for_IN all_DT
          subsequent_JJ experiments_NNS to_TO ensure_VB peak_NN abundance_NN of_IN the_DT
          induced_VBN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN ._.
          As_IN shown_VBN in_IN Figure_NN 2_CD C_NNP ,_, a_DT significant_JJ reduction_NN in_IN
          6_CD His-_NNP HA-PP_NNP 1_CD α_NN abundance_NN can_MD be_VB observed_VBN between_IN 3_CD and_CC 12_CD
          hrs_NNS following_VBG removal_NN of_IN doxycycline_NN ._. This_DT reduction_NN
          continued_VBD through_IN the_DT 24_CD hr_NN time_NN point_NN at_IN which_WDT time_NN the_DT
          experiment_NN ended_VBD ._. Taken_VBN together_RB ,_, these_DT data_NNS confirm_VBP the_DT
          dependence_NN of_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN protein_NN production_NN on_IN the_DT
          tet-_NN O_NNP /_NN CMV_NNP promoter_NN ,_, thus_RB demonstrating_VBG inducible_JJ
          expression_NN of_IN PP_NNP 1_CD α_NN ._. As_IN expected_VBN [_NN 25_CD ]_NN ,_, some_DT low-level_JJ
          expression_NN of_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN in_IN the_DT absence_NN of_IN the_DT inducer_NN
          doxycycline_NN can_MD also_RB be_VB detected_VBN ._.
        
        
          Biological_NNP and_CC Biochemical_NNP Characterization_NNP of_IN
          Inducible_NNP 6_CD His-_NNP HA-PP_NNP 1_CD α_NN
          To_TO begin_VB addressing_VBG the_DT biological_JJ and_CC biochemical_JJ
          characterization_NN of_IN inducible_JJ PP_NNP 1_CD α_NN ,_, we_PRP next_JJ localized_JJ
          this_DT protein_NN 
          in_IN situ_NN using_VBG immunohistochemistry_NN ._.
          As_IN shown_VBN in_IN Figure_NN 3_CD ,_, there_EX is_VBZ a_DT predominant_NN nuclear_JJ
          localization_NN of_IN the_DT hemagglutinin_NN epitope_NN (_( panel_NN A_DT )_)
          compared_VBN to_TO the_DT low-level_JJ cytoplasmic_JJ and_CC nuclear_JJ
          background_NN reactivity_NN seen_VBN in_IN the_DT uninduced_JJ LLWO_NNP 2_CD F_NN
          control_NN cells_NNS (_( panel_NN B_NNP )_) ._. Thus_RB ,_, not_RB only_RB can_MD
          doxycycline-induced_JJ expression_NN of_IN PP_NNP 1_CD α_NN be_VB detected_VBN
          immunohistochemically_RB ,_, but_CC localization_NN of_IN this_DT protein_NN
          appears_VBZ to_TO be_VB identical_JJ to_TO that_DT of_IN endogenous_JJ PP_NNP 1_CD [_NN 26_CD ]_NN
          ._.
          Targeting_NNP of_IN PP_NNP 1_CD to_TO the_DT nucleus_NN is_VBZ due_JJ in_IN part_NN to_TO a_DT
          PP_NNP 1_CD -_: associated_VBN nuclear_JJ targeting_VBG subunit_NN (_( PNUTS_NNP ;_: [_NN 27_CD ]_NN
          )_) ._. To_TO further_VB investigate_VB the_DT properties_NNS of_IN inducible_JJ
          PP_NNP 1_CD α_NN ,_, we_PRP performed_VBD coprecipitation_NN studies_NNS to_TO determine_VB
          if_IN PNUTS_NNP can_MD also_RB be_VB found_VBN associated_VBN with_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN ._.
          Towards_NNP this_DT goal_NN ,_, a_DT fusion_NN protein_NN of_IN GST_NNP and_CC PNUTS_NNP was_VBD
          tested_VBN for_IN the_DT ability_NN to_TO capture_VB induced_VBN PP_NNP 1_CD α_NN ._. Lysates_NNP
          from_IN induced_VBN LLWO_NNP 2_CD F_NN cells_NNS were_VBD combined_VBN with_IN GST-alone-_NNP
          or_CC GST-PNUTS-loaded_NNP glutathione_NN Sepharose_NNP beads_NNS ._.
          Following_VBG separation_NN by_IN SDS-PAGE_NNP and_CC western_JJ blotting_VBG ,_,
          antibody_NN to_TO hemagglutinin_NN was_VBD used_VBN to_TO detect_VB any_DT
          associated_VBN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN ._. Antibody_NNP reactivity_NN would_MD
          indicate_VB a_DT link_NN from_IN the_DT GST_NNP epitope_NN to_TO the_DT hemagglutinin_NN
          epitope_NN via_IN a_DT PNUTS_NNP to_TO PP_NNP 1_CD α_NN interaction_NN ._. As_IN shown_VBN in_IN
          Figure_NN 4_CD ,_, the_DT hemagglutinin_NN epitope_NN was_VBD captured_VBN by_IN the_DT
          GST-PNUTS_NNP fusion_NN protein_NN ,_, but_CC not_RB the_DT GST-alone_NNP protein_NN ._.
          These_DT data_NNS support_VBP the_DT idea_NN that_WDT induced_VBD PP_NNP 1_CD α_NN and_CC the_DT
          nuclear_JJ targeting_VBG PP_NNP 1_CD -_: associated_VBN protein_NN PNUTS_NNP can_MD form_VB a_DT
          complex_NN ._. These_DT results_NNS further_JJ support_NN the_DT view_NN that_WDT
          induced_VBD PP_NNP 1_CD α_NN behaves_VBZ similarly_RB if_IN not_RB identically_RB to_TO
          endogenous_JJ PP_NNP 1_CD α_NN ,_, and_CC provides_VBZ a_DT possible_JJ mechanistic_JJ
          explanation_NN for_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN localization_NN to_TO the_DT
          nucleus_NN ._.
          Two_CD different_JJ approaches_NNS were_VBD taken_VBN to_TO address_VB the_DT
          biochemical_JJ activity_NN of_IN inducible_JJ PP_NNP 1_CD α_NN ._. First_LS ,_,
          immunocomplexed_JJ 6_CD His-_NNP HA-PP_NNP 1_CD α_NN was_VBD tested_VBN for_IN its_PRP$ ability_NN
          to_TO dephosphorylate_NN phosphorylase_NN 
          a_DT ._. Phosphorylated_NNP on_IN a_DT single_JJ
          serine_NN residue_NN ,_, this_DT substrate_NN is_VBZ often_RB used_VBN to_TO monitor_VB
          the_DT biochemical_JJ activity_NN of_IN PP_NNP 1_CD 
          in_IN vitro_NN [_NN 28_CD ]_NN ._. As_IN shown_VBN in_IN
          Figure_NN 5_CD ,_, greater_JJR phosphatase_NN activity_NN is_VBZ detected_VBN in_IN
          immunoprecipitates_NNS from_IN induced_VBN LLWO_NNP 2_CD F_NN cell_NN lysates_NNS
          compared_VBN to_TO uninduced_JJ ._. This_DT is_VBZ consistent_JJ with_IN the_DT notion_NN
          that_IN inducible_JJ PP_NNP 1_CD α_NN is_VBZ enzymatically_RB active_JJ ._. Our_PRP$ second_JJ
          approach_NN involved_VBD testing_NN immunopurified_JJ 6_CD His-_NNP HA-PP_NNP 1_CD α_NN for_IN
          its_PRP$ ability_NN to_TO dephosphorylate_NN the_DT growth_NN suppressor_NN
          protein_NN pRB_NN ._. Having_VBG previously_RB reported_VBD on_IN the_DT ability_NN of_IN
          immunocomplexed_JJ endogenous_JJ PP_NNP 1_CD to_TO dephosphorylate_NN pRB_NN [_NN
          20_CD ]_NN ,_, we_PRP followed_VBD the_DT same_JJ experimental_JJ approach_NN ._. Figure_NN
          6_CD shows_VBZ a_DT significant_JJ decrease_NN in_IN the_DT 32_CD P_NN radiolabel_NN
          intensity_NN for_IN pRB_NN following_VBG incubation_NN with_IN the_DT
          anti-hemagglutinin_JJ immunoprecipitate_NN compared_VBN to_TO the_DT
          normal_JJ mouse_NN IgG_NNP control_NN immunoprecipitate_NN ._. In_IN addition_NN ,_,
          okadaic_JJ acid_NN ,_, a_DT potent_JJ inhibitor_NN of_IN PP_NNP 1_CD activity_NN [_NN 29_CD ]_NN ,_,
          significantly_RB inhibits_NNS pRB_NN dephosphorylation_NN in_IN this_DT
          reaction_NN ._. Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN
          inducible_JJ PP_NNP 1_CD α_NN is_VBZ biochemically_RB active_JJ ._.
        
        
          Upregulation_NNP of_IN inducible_JJ 6_CD His-_NNP HA-PP_NNP 1_CD α_NN coincides_VBZ
          with_IN downregulation_NN of_IN endogenous_JJ PP_NNP 1_CD α_NN
          One_CD prediction_NN would_MD be_VB that_IN by_IN increasing_VBG expression_NN
          of_IN the_DT catalytic_JJ subunit_NN of_IN PP_NNP 1_CD α_NN ,_, overall_JJ PP_NNP 1_CD -_: specific_JJ
          activity_NN within_IN the_DT cell_NN would_MD increase_VB ._. To_TO address_VB this_DT ,_,
          we_PRP tested_VBD the_DT phosphatase_NN activity_NN of_IN LLWO_NNP 2_CD F_NN whole-cell_JJ
          lysate_NN using_VBG phosphorylase_NN 
          a_DT as_IN the_DT substrate_NN ._. To_TO inhibit_VB any_DT
          endogenous_JJ PP_NNP 2_CD A_DT activity_NN ,_, which_WDT can_MD also_RB dephosphorylate_NN
          phosphorylase_NN 
          a_DT and_NN thus_RB interfere_VB with_IN PP_NNP 1_CD
          activity_NN measurements_NNS ,_, these_DT assays_NNS were_VBD carried_VBN out_IN in_IN
          the_DT presence_NN of_IN 5_CD nM_NN okadaic_JJ acid_NN ,_, which_WDT does_VBZ not_RB inhibit_VB
          PP_NNP 1_CD activity_NN [_NN 30_CD ]_NN ._. Although_IN reproducible_JJ ,_, we_PRP observed_VBD
          only_RB modest_JJ increases_NNS in_IN PP_NNP 1_CD -_: specific_JJ activity_NN found_VBD in_IN
          lysates_NNS from_IN induced_VBN cells_NNS compared_VBN to_TO the_DT uninduced_JJ
          controls_NNS (_( Figure_NN 7_CD )_) ._. One_CD possible_JJ explanation_NN for_IN this_DT
          finding_VBG is_VBZ that_IN the_DT overall_JJ level_NN of_IN PP_NNP 1_CD α_NN within_IN the_DT cell_NN
          remains_VBZ relatively_RB constant_JJ regardless_RB of_IN induction_NN ._.
          Indeed_RB ,_, a_DT time_NN course_NN of_IN induction_NN followed_VBN by_IN western_JJ
          blotting_VBG of_IN whole_JJ cell_NN lysates_NNS using_VBG antibody_NN to_TO PP_NNP 1_CD α_NN
          revealed_VBD diminution_NN of_IN the_DT endogenous_JJ PP_NNP 1_CD α_NN signal_NN after_IN 4_CD
          hr_NN of_IN induction_NN ,_, while_IN the_DT 6_CD His-_NNP HA-PP_NNP 1_CD α_NN signal_NN increased_VBD
          (_( Figure_NN 8_CD )_) ._. To_TO further_VB test_NN this_DT hypothesis_NNS ,_,
          immunoprecipitation_NN and_CC western_JJ blotting_VBG experiments_NNS were_VBD
          carried_VBN out_IN using_VBG PP_NNP 1_CD isoform-specific_JJ antibodies_NNS ._. As_IN
          shown_VBN in_IN Figure_NN 9_CD ,_, top_JJ panel_NN ,_, induced_VBN (_( approximate_JJ
          molecular_JJ weight_NN of_IN 40_CD kDa_NN )_) and_CC endogenous_JJ (_( approximate_JJ
          molecular_JJ weight_NN of_IN 37_CD kDa_NN )_) PP_NNP 1_CD α_NN are_VBP clearly_RB resolved_VBN by_IN
          SDS-PAGE_NNP ._. As_IN predicted_VBD ,_, both_DT proteins_NNS are_VBP recognized_VBN by_IN
          antibody_NN specific_JJ for_IN PP_NNP 1_CD α_NN when_WRB performing_VBG
          immunoprecipitation_NN or_CC western_JJ blotting_VBG ._.
          Immunoprecipitation_NNP using_VBG PP_NNP 1_CD α_NN antibody_NN followed_VBN by_IN
          western_JJ blotting_VBG using_VBG the_DT same_JJ anti-_NN PP_NNP 1_CD α_NN reveals_VBZ a_DT
          reciprocal_JJ relationship_NN in_IN PP_NNP 1_CD α_NN abundance_NN following_VBG
          doxycycline_NN induction_NN ;_: endogenous_JJ PP_NNP 1_CD α_NN levels_NNS decrease_VBP in_IN
          response_NN to_TO increasing_VBG levels_NNS of_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN (_( top_JJ panel_NN ,_,
          compare_VB left_VBD two_CD lanes_NNS )_) ._. This_DT difference_NN in_IN abundance_NN is_VBZ
          more_RBR striking_VBG in_IN the_DT whole-cell_JJ lysate_NN lanes_NNS ;_: endogenous_JJ
          PP_NNP 1_CD α_NN fails_VBZ to_TO be_VB detected_VBN in_IN lysates_NNS prepared_VBN from_IN
          induced_VBN cells_NNS (_( compare_VB middle_JJ two_CD lanes_NNS )_) ._. Parallel_JJ
          experiments_NNS performed_VBD using_VBG the_DT same_JJ lysate_NN and_CC antibody_NN
          to_TO hemagglutinin_NN for_IN immunoprecipitation_NN and_CC western_JJ
          blotting_VBG show_NN the_DT position_NN of_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN and_CC the_DT fact_NN
          that_IN endogenous_JJ PP_NNP 1_CD α_NN is_VBZ not_RB recognized_VBN by_IN this_DT antibody_NN
          (_( bottom_JJ panel_NN )_) ._. Western_NNP blotting_VBG for_IN additional_JJ isoforms_NNS
          of_IN PP_NNP 1_CD reveals_VBZ that_IN this_DT reduction_NN in_IN PP_NNP 1_CD α_NN following_VBG
          induction_NN is_VBZ isotype-specific_JJ ;_: when_WRB 6_CD His-_NNP HA-PP_NNP 1_CD α_NN levels_NNS
          increase_NN ,_, concomitant_NN with_IN a_DT decrease_NN in_IN PP_NNP 1_CD α_NN levels_NNS ,_,
          PP_NNP 1_CD δ_NN and_CC PP_NNP 1_CD γ_NN 1_CD levels_NNS remain_VBP relatively_RB unchanged_JJ from_IN
          those_DT found_VBN in_IN uninduced_JJ cell_NN lysate_NN (_( Figure_NN 10_CD )_) ._. Taken_VBN
          together_RB ,_, these_DT data_NNS suggest_VBP that_IN an_DT as_RB yet_RB undescribed_JJ
          negative-feedback_JJ or_CC autoregulatory_NN mechanism_NN exists_VBZ for_IN
          PP_NNP 1_CD α_NN which_WDT contributes_VBZ towards_IN maintaining_VBG a_DT constant_JJ
          level_NN of_IN protein_NN expression_NN and_CC enzyme_NN activity_NN ._.
        
        
          RT-PCR_NNP of_IN polysome_NN and_CC total_JJ RNA_NNP specific_JJ for_IN
          endogenous_JJ PP_NNP 1_CD α_NN and_CC 6_CD His-_NNP HA-PP_NNP 1_CD α_NN
          To_TO address_VB the_DT possible_JJ autoregulatory_NN mechanism_NN (_( s_VBZ )_) of_IN
          PP_NNP 1_CD α_NN expression_NN and_CC activity_NN ,_, we_PRP analyzed_VBD the_DT RNA_NNP levels_NNS
          of_IN both_DT endogenous_JJ PP_NNP 1_CD α_NN and_CC induced_VBN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN ._. For_IN
          uninduced_JJ cells_NNS ,_, only_RB endogenous_JJ PP_NNP 1_CD α_NN RNA_NNP can_MD be_VB found_VBN
          associated_VBN with_IN polysomes_NNS (_( Figure_NN 11_CD ,_, second_JJ lane_NN )_) ._. While_IN
          some_DT 6_CD His-_NNP HA-PP_NNP 1_CD α_NN RNA_NNP can_MD be_VB detected_VBN in_IN the_DT total_JJ RNA_NNP ,_,
          the_DT majority_JJ PP_NNP 1_CD α_NN RNA_NNP detected_VBD in_IN the_DT total_JJ preparation_NN
          is_VBZ endogenous_JJ (_( fourth_JJ lane_NN )_) ._. In_IN contrast_NN ,_, it_PRP appears_VBZ that_IN
          for_IN the_DT doxycycline-induced_JJ cells_NNS (_( third_JJ lane_NN )_) ,_, there_EX is_VBZ
          more_JJR 6_CD His-_NNP HA-PP_NNP 1_CD α_NN RNA_NNP associated_VBN with_IN polysomes_NNS than_IN
          endogenous_JJ PP_NNP 1_CD α_NN ._. However_RB ,_, both_DT messages_NNS appear_VBP to_TO be_VB
          present_JJ at_IN the_DT same_JJ level_NN in_IN the_DT total_JJ RNA_NNP preparation_NN
          (_( fifth_JJ lane_NN )_) ._. This_DT apparent_JJ preference_NN for_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN
          RNA_NNP association_NN with_IN polysomes_NNS suggest_VBP that_DT
          autoregulation_NN takes_VBZ place_NN ,_, at_IN least_JJS in_IN part_NN ,_, at_IN the_DT
          translational_NN level_NN ._.
        
      
      
        Conclusions_NNP
        In_IN summary_NN ,_, we_PRP report_VBP on_IN the_DT development_NN of_IN an_DT inducible_JJ
        mammalian_JJ cell_NN expression_NN system_NN for_IN the_DT catalytic_JJ subunit_NN
        of_IN the_DT α-isotype_JJ for_IN PP_NNP 1_CD ._. This_DT protein_NN behaves_VBZ similarly_RB if_IN
        not_RB identically_RB to_TO endogenous_JJ PP_NNP 1_CD α_NN with_IN respect_NN to_TO nuclear_JJ
        localization_NN ,_, complex_JJ formation_NN to_TO a_DT recently_RB described_VBN
        PP_NNP 1_CD -_: associated_VBN nuclear_JJ targeting_VBG protein_NN ,_, and_CC 
        in_IN vitro_NN enzymatic_JJ activity_NN towards_IN
        phosphorylase_NN 
        a_DT and_NN the_DT cell_NN growth_NN and_CC tumor_NN
        suppressor_NN protein_NN pRB_NN ._.
        We_PRP observed_VBD that_IN endogenous_JJ PP_NNP 1_CD α_NN protein_NN levels_NNS decrease_VBP
        in_IN response_NN to_TO increasing_VBG levels_NNS of_IN induced_VBN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN
        protein_NN ._. This_DT observation_NN suggests_VBZ that_IN an_DT as_RB yet_RB
        undescribed_JJ negative-feedback_JJ or_CC autoregulatory_NN mechanism_NN
        exists_VBZ for_IN PP_NNP 1_CD α_NN which_WDT contributes_VBZ towards_IN maintaining_VBG a_DT
        constant_JJ level_NN of_IN this_DT enzyme_NN ._. Given_VBN the_DT difficulty_NN in_IN
        achieving_VBG overexpression_NN of_IN PP_NNP 1_CD protein_NN and_CC activity_NN in_IN
        mammalian_JJ cells_NNS ,_, this_DT suggestion_NN provides_VBZ an_DT attractive_JJ
        explanation_NN ._. This_DT putative_JJ mechanism_NN appears_VBZ to_TO be_VB
        isotype-specific_JJ ,_, since_IN the_DT protein_NN levels_NNS of_IN PP_NNP 1_CD δ_NN and_CC
        PP_NNP 1_CD γ_NN 1_CD remained_VBD relatively_RB unchanged_JJ in_IN response_NN to_TO induced_VBN
        expression_NN of_IN PP_NNP 1_CD α_NN ._. Precedent_NNP for_IN an_DT autoregulatory_NN
        mechanism_NN comes_VBZ from_IN a_DT report_NN by_IN Baharians_NNP and_CC Schonthal_NNP [_NN
        31_CD ]_NN ,_, in_IN which_WDT they_PRP demonstrate_VBP endogenous_JJ PP_NNP 2_CD A_DT protein_NN
        levels_NNS decrease_VBP in_IN the_DT presence_NN of_IN increasing_VBG amounts_NNS of_IN
        forcibly-expressed_JJ exogenous_JJ PP_NNP 2_CD A_DT ._. Their_PRP$ report_NN also_RB
        provides_VBZ evidence_NN that_IN this_DT control_NN is_VBZ exerted_VBN at_IN the_DT
        translational_NN level_NN and_CC does_VBZ not_RB involve_VB regulation_NN of_IN
        transcription_NN or_CC RNA_NNP processing_NN ._. Using_VBG a_DT similar_JJ approach_NN
        of_IN analyzing_VBG mRNA_NN association_NN with_IN ribosomes_NNS as_IN a_DT measure_NN
        of_IN translation_NN efficiency_NN ,_, a_DT similar_JJ level_NN of_IN translational_NN
        control_NN also_RB appears_VBZ to_TO exist_VB for_IN PP_NNP 1_CD α_NN ._. If_IN mRNA_NN association_NN
        with_IN ribosomes_NNS is_VBZ truly_RB a_DT measure_NN of_IN translation_NN
        efficiency_NN ,_, one_CD conclusion_NN from_IN these_DT data_NNS is_VBZ that_IN in_IN
        doxycycline-induced_JJ cells_NNS ,_, 6_CD His-_NNP HA-PP_NNP 1_CD α_NN RNA_NNP is_VBZ more_RBR
        efficiently_RB translated_VBN than_IN endogenous_JJ PP_NNP 1_CD α_NN ._. This_DT would_MD
        help_VB to_TO explain_VB why_WRB we_PRP observed_VBD a_DT decrease_NN in_IN endogenous_JJ
        PP_NNP 1_CD α_NN protein_NN expression_NN in_IN doxycycline-induced_JJ cells_NNS ._. Since_IN
        we_PRP did_VBD not_RB perform_VB rigorous_JJ analyses_NNS on_IN PP_NNP 1_CD α_NN regulation_NN of_IN
        transcription_NN or_CC RNA_NNP processing_NN ,_, we_PRP cannot_NN rule_NN out_RP the_DT
        possibility_NN that_IN some_DT level_NN of_IN transcriptional_NN control_NN also_RB
        exists_VBZ ._. Indeed_RB ,_, the_DT abundance_NN of_IN endogenous_JJ PP_NNP 1_CD α_NN RNA_NNP found_VBD
        in_IN uninduced_JJ cells_NNS appears_VBZ equal_JJ to_TO or_CC greater_JJR than_IN the_DT
        combined_VBN abundance_NN of_IN endogenous_JJ and_CC 6_CD His-_NNP HA-PP_NNP 1_CD α_NN RNA_NNP
        (_( Figure_NN 9_CD )_) ,_, supporting_VBG the_DT notion_NN that_IN some_DT level_NN of_IN
        translational_NN control_NN may_MD also_RB exist_VB ._.
        These_DT findings_NNS ,_, provided_VBN by_IN the_DT development_NN of_IN this_DT
        inducible_JJ PP_NNP 1_CD expression_NN system_NN ,_, will_MD afford_VB new_JJ research_NN
        opportunities_NNS aimed_VBN towards_IN addressing_VBG the_DT question_NN of_IN how_WRB
        PP_NNP 1_CD activity_NN is_VBZ regulated_VBN ._. This_DT putative_JJ autoregulatory_NN
        mechanism_NN for_IN the_DT catalytic_JJ subunit_NN may_MD help_VB to_TO explain_VB why_WRB
        the_DT overall_JJ abundance_NN of_IN PP_NNP 1_CD during_IN the_DT various_JJ phases_NNS of_IN
        the_DT cell_NN cycle_NN remains_VBZ relatively_RB constant_JJ [_NN 32_CD ]_NN ._.
        Historically_NNP ,_, regulation_NN of_IN PP_NNP 1_CD catalytic_JJ activity_NN has_VBZ
        resulted_VBN from_IN associated_VBN subunits_NNS inhibiting_VBG or_CC targeting_VBG
        the_DT catalytic_JJ subunit_NN towards_IN substrates_NNS [_NN 33_CD ]_NN ._. While_IN the_DT
        PP_NNP 1_CD catalytic_JJ subunit_NN is_VBZ not_RB found_VBN alone_RB in_IN the_DT cell_NN ,_, such_JJ
        unassociated_JJ catalytic_JJ subunits_NNS have_VBP been_VBN shown_VBN to_TO be_VB
        active_JJ ,_, at_IN least_JJS 
        in_IN vitro_NN ._. Although_IN speculative_JJ ,_,
        there_EX may_MD be_VB a_DT threshold_NN amount_NN of_IN catalytic_JJ subunit_NN 
        in_IN vivo_NN above_IN which_WDT associated_VBN
        proteins_NNS are_VBP limiting_VBG ._. Such_JJ a_DT situation_NN may_MD compromise_VB the_DT
        ability_NN of_IN associated_VBN proteins_NNS to_TO effectively_RB regulate_VB PP_NNP 1_CD
        catalytic_JJ activity_NN ._. To_TO guard_VB against_IN this_DT scenario_NN ,_, control_NN
        over_IN the_DT amount_NN of_IN PP_NNP 1_CD catalytic_JJ subunit_NN present_JJ via_IN an_DT
        autoregulatory_NN mechanism_NN would_MD be_VB beneficial_JJ ._.
        The_DT data_NNS presented_VBN here_RB validate_NN a_DT useful_JJ system_NN with_IN
        which_WDT to_TO manipulate_VB PP_NNP 1_CD activity_NN 
        in_IN vivo_NN for_IN the_DT purpose_NN of_IN functional_JJ
        studies_NNS ._. Just_RB as_IN is_VBZ the_DT case_NN for_IN PP_NNP 2_CD A_DT [_NN 31_CD ]_NN ,_, it_PRP seems_VBZ
        clear_JJ that_IN efficient_JJ overall_JJ increases_NNS in_IN PP_NNP 1_CD protein_NN
        abundance_NN may_MD not_RB be_VB achieved_VBN due_JJ to_TO a_DT putative_JJ negative_JJ
        feed-back_JJ or_CC autoregulatory_NN mechanism_NN ._. However_RB ,_, induced_VBN
        expression_NN of_IN exogenous_JJ PP_NNP 1_CD which_WDT behaves_VBZ identically_RB to_TO
        endogenous_JJ PP_NNP 1_CD while_IN remaining_VBG physically_RB distinguishable_JJ
        can_MD facilitate_VB the_DT use_NN of_IN mutants_NNS to_TO address_VB functional_JJ
        questions_NNS ,_, particularly_RB in_IN the_DT area_NN of_IN cell_NN cycle_NN
        regulation_NN and_CC tumor_NN cell_NN growth_NN suppression_NN ._. Indeed_RB ,_, the_DT
        use_NN of_IN a_DT constitutively_RB active_JJ mutant_JJ of_IN PP_NNP 1_CD has_VBZ already_RB
        been_VBN shown_VBN to_TO result_VB in_IN pRB-dependent_JJ G_NNP 1_CD arrest_NN in_IN human_JJ
        cancer_NN cells_NNS [_NN 22_CD ]_NN ._. Placing_NNP this_DT mutant_JJ into_IN the_DT
        inducible_JJ expression_NN system_NN described_VBD here_RB has_VBZ the_DT
        potential_NN to_TO down-regulate_JJ expression_NN of_IN wild-type_JJ
        endogenous_JJ PP_NNP 1_CD ._. Doing_VBG so_RB in_IN a_DT timed_VBN ,_, controlled_VBN manner_NN will_MD
        permit_VB 
        in_IN vivo_NN studies_NNS addressing_VBG PP_NNP 1_CD
        function_NN during_IN discrete_JJ phases_NNS of_IN the_DT cell_NN cycle_NN ,_, and_CC will_MD
        be_VB the_DT subject_NN of_IN future_JJ endeavors_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Tetracycline_NNP Induction_NNP System_NNP
          The_DT rabbit_NN PP_NNP 1_CD α_NN cDNA_NN in_IN pDR_NN 540_CD [_NN 34_CD ]_NN was_VBD ligated_JJ into_IN
          pcDNA_NN 3_CD (_( Invitrogen_NNP )_) to_TO create_VB a_DT fusion_NN encoding_VBG 6_CD
          histidines_NNS (_( 6_CD -_: His_PRP$ )_) followed_VBN by_IN an_DT epitope_NN (_( YPYDVPDYA_NNP )_)
          from_IN the_DT 
          Hemophilus_NNP influenza_NN hemagglutinin_NN
          protein_NN (_( HA_NNP )_) ._. The_DT sequence_NN and_CC reading_NN frame_NN was_VBD
          validated_JJ by_IN BigDye_NNP DNA_NNP sequencing_VBG (_( PE_NNP Applied_NNP
          Biosystems_NNP )_) ._. The_DT fusion_NN gene_NN was_VBD then_RB cut_VB from_IN the_DT
          6_CD His-_NNP HA-PP_NNP 1_CD α-pc_JJ DNA_NNP 3_CD plasmid_NN and_CC ligated_JJ into_IN pTEP_NN 4_CD m_NN ,_,
          which_WDT contains_VBZ a_DT tetracycline_NN response_NN element_NN for_IN
          inducible_JJ expression_NN [_NN 25_CD ]_NN ,_, and_CC a_DT hygromycin_NN resistance_NN
          gene_NN for_IN selection_NN in_IN eukaryotic_JJ cells_NNS (_( see_VB Figure_NN 1_LS )_) ._.
          pUHD_NN 172_CD -_: 1_CD neo_NN [_NN 25_CD ]_NN encodes_NNS the_DT reverse_JJ tetracycline_NN
          transactivator_NN protein_NN fused_JJ with_IN a_DT nuclear_JJ localization_NN
          signal_NN (_( rtTA-nls_JJ )_) ._. In_IN addition_NN to_TO the_DT rtTA-nls_JJ gene_NN under_IN
          control_NN of_IN the_DT CMV_NNP promoter_NN ,_, the_DT plasmid_NN contains_VBZ
          neomycin_NN and_CC ampicillin_NN antibiotic_JJ resistance_NN genes_NNS ._.
        
        
          Cell_NNP Culture_NNP ,_, Transfection_NNP ,_, and_CC Selection_NN
          The_DT UMUC_NNP 3_CD cell_NN line_NN was_VBD obtained_VBN from_IN the_DT American_NNP
          Type_NNP Culture_NNP Collection_NNP ._. The_DT cells_NNS were_VBD maintained_VBN in_IN
          Dulbecco_NNP 's_POS minimal_JJ essential_JJ medium_NN (_( Life_NNP Technologies_NNPS )_)
          supplemented_JJ with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN ,_, 20_CD units_NNS /_NN ml_NN
          penicillin_NN and_CC 20_CD ug_NN /_NN ml_NN streptomycin_NN ._. Cells_NNP were_VBD
          incubated_JJ at_IN 37_CD C_NNP ,_, in_IN a_DT 5_CD %_NN carbon_NN dioxide_NN containing_VBG
          atmosphere_NN ._.
          Plasmid_NNP DNA_NNP was_VBD introduced_VBN into_IN cultured_JJ cells_NNS using_VBG
          Lipofectamine_NNP (_( Life_NNP Technologies_NNPS )_) ._. 2_LS ug_NN of_IN plasmid_NN DNA_NNP
          and_CC 25_CD ul_NN of_IN Lipofectamine_NNP were_VBD combined_VBN in_IN 200_CD ul_NN of_IN
          Opti-mem_NNP media_NNS (_( Life_NNP Technologies_NNPS )_) and_CC allowed_VBN to_TO stand_VB
          at_IN room_NN temperature_NN for_IN 30_CD minutes_NNS ._. This_DT mixture_NN was_VBD
          diluted_VBN to_TO 1_CD ml_NN with_IN Opti-mem_NNP and_CC applied_VBN to_TO cells_NNS in_IN one_CD
          well_RB of_IN 6_CD -_: well_RB tissue_NN culture_NN plates_NNS ._. After_IN two_CD hours_NNS ,_, 1_CD
          ml_NN of_IN complete_JJ medium_NN was_VBD added_VBN to_TO each_DT well_RB ._. After_IN
          twenty-four_JJ hours_NNS the_DT medium_NN was_VBD replaced_VBN with_IN complete_JJ
          medium_NN ._.
          Transfection_NNP of_IN UMUC_NNP 3_CD cells_NNS with_IN pUHD_NN 172_CD -_: 1_CD neo_NN was_VBD
          followed_VBN 48_CD hr_NN later_RB by_IN selection_NN using_VBG geneticin_NN ._.
          Isolated_NNP colonies_NNS were_VBD obtained_VBN at_IN 800_CD μg_NN /_NN ml_NN ._. These_DT cells_NNS
          were_VBD passaged_JJ and_CC expanded_VBN before_IN transfection_NN with_IN
          pBI-EGFP_JJ (_( Clontech_NNP )_) ,_, which_WDT contains_VBZ the_DT enhanced_VBN green_JJ
          fluorescent_NN protein_NN coding_VBG sequence_NN under_IN control_NN of_IN a_DT
          bi-directional_JJ tetracycline_NN response_NN element_NN ._. At_IN the_DT end_NN
          of_IN the_DT 2_CD hr_NN transfection_NN (_( as_IN described_VBN above_IN )_) the_DT medium_NN
          was_VBD replaced_VBN with_IN complete_JJ medium_NN with_IN and_CC without_IN
          doxycycline_NN at_IN 1_CD ug_NN /_NN ml_NN final_JJ concentration_NN ._. 24_CD hr_NN later_RB
          the_DT cells_NNS were_VBD examined_VBN by_IN fluorescence_NN microscopy_NN ._. The_DT
          presence_NN of_IN doxycycline_NN dependent_JJ green_JJ fluorescence_NN was_VBD
          indicative_JJ of_IN stable_JJ transfection_NN with_IN pUHD_NN 172_CD -_: 1_CD neo_NN
          encoding_VBG the_DT rtTA-nls_JJ protein_NN and_CC transient_JJ transfection_NN
          with_IN pBi-EGFP_JJ ._. Parallel_JJ cultures_NNS were_VBD then_RB passaged_JJ and_CC
          transfected_JJ with_IN 6_CD His-_NNP HA-PP_NNP 1_CD α-p_JJ TEP_NNP 4_CD m_NN ._. Selection_NN with_IN
          hygromycin_NN was_VBD begun_VBN 48_CD hr_NN later_RB ._. Isolated_NNP colonies_NNS were_VBD
          obtained_VBN at_IN 100_CD ug_NN /_NN ml_NN hygromycin_NN and_CC were_VBD passaged_JJ and_CC
          diluted_VBN to_TO extinction_NN ._. Six_CD cell_NN lines_NNS ,_, designated_VBN LLW_NNP 02_CD A_DT
          through_IN LLW_NNP 02_CD F_NN ,_, were_VBD established_VBN ._. The_DT LLW_NNP 02_CD F_NN cell_NN line_NN
          was_VBD used_VBN for_IN all_DT subsequent_JJ experiments_NNS ._. This_DT choice_NN was_VBD
          based_VBN on_IN high_JJ levels_NNS of_IN induced_VBN PP_NNP 1_CD α_NN expression_NN as_IN
          assayed_JJ by_IN immunoblotting_VBG ._. Doxycycline_NNP was_VBD used_VBN at_IN 1_CD
          ug_NN /_NN ml_NN for_IN induction_NN ._.
        
        
          SDS-PAGE_NNP and_CC Immunoblotting_NNP
          Cells_NNP were_VBD lysed_JJ for_IN 15_CD min_NN at_IN 4_CD °_NN C_NNP in_IN EBC_NNP buffer_NN (_( 50_CD
          mM_NN Tris-_NNP HCl_NNP ,_, pH_NN 8_CD ._. 0_CD ,_, 120_CD mM_NN NaCl_NNP ,_, 0_CD ._. 5_CD %_NN Nonidet_NNP P-_NNP 40_CD )_)
          containing_VBG 10_CD ug_NN /_NN ml_NN of_IN the_DT protease_NN inhibitors_NNS aprotinin_NN ,_,
          leupeptin_NN ,_, and_CC phenylmethylsulfonylfluoride_NN (_( PMSF_NNP )_) ._. The_DT
          lysates_NNS were_VBD cleared_VBN by_IN centrifugation_NN at_IN 14_CD ,_, 000_CD ×_NN g_SYM for_IN
          10_CD minutes_NNS ._. Electrophoresis_NNP was_VBD performed_VBN in_IN
          SDS-polyacrylamide_NNP gels_NNS [_NN 35_CD ]_NN using_VBG the_DT indicated_VBN amount_NN
          of_IN total_JJ cell_NN protein_NN [_NN 36_CD ]_NN ._. After_IN electrophoresis_NNS ,_, the_DT
          proteins_NNS were_VBD transferred_VBN to_TO nitrocellulose_NN paper_NN in_IN
          buffer_NN containing_VBG 25_CD mM_NN Tris-_NNP HCl_NNP ,_, 192_CD mM_NN glycine_NN ,_, 20_CD %_NN v_NN /_NN v_NN
          methanol_NN ,_, and_CC 0_CD ._. 01_CD %_NN SDS_NNP ,_, pH_NN 8_CD ._. 5_CD [_NN 37_CD ]_NN ._. Residual_NNP protein_NN
          binding_JJ sites_NNS on_IN the_DT nitrocellulose_NN were_VBD blocked_VBN by_IN
          incubation_NN for_IN 30_CD minutes_NNS in_IN TBST_NNP (_( 25_CD mM_NN Tris-_NNP HCl_NNP ,_, pH_NN
          8_CD ._. 0_CD ,_, 150_CD mM_NN NaCl_NNP ,_, 0_CD ._. 5_CD %_NN Tween-_NNP 20_CD )_) containing_VBG 4_CD %_NN non-fat_JJ
          dry_JJ milk_NN ._. Next_JJ ,_, the_DT nitrocellulose_NN was_VBD incubated_JJ in_IN TBST_NNP
          containing_VBG 2_CD %_NN non-fat_JJ dry_JJ milk_NN containing_VBG primary_JJ
          antibody_NN directed_VBN towards_IN the_DT indicated_VBN protein_NN ._.
          Following_VBG three_CD washes_NNS of_IN 10_CD min_NN each_DT with_IN TBST_NNP ,_, the_DT
          nitrocellulose_NN was_VBD probed_JJ with_IN horse-radish_JJ
          peroxidase-conjugated_JJ anti-_NN IgG_NNP (_( Promega_NNP ,_, Madison_NNP ,_, WI_NNP )_) and_CC
          developed_VBN using_VBG chemiluminescence_NN detection_NN (_( Pierce_NNP ,_,
          Rockford_NNP ,_, IL_NNP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS
          instructions_NNS ._.
        
        
          Immunohistochemistry_NNP
          Cell_NNP monolayers_NNS were_VBD rinsed_JJ 3_CD times_NNS with_IN PBS_NNP ,_, fixed_VBN
          for_IN 10_CD minutes_NNS in_IN -_: 20_CD oC_NN methanol_NN ,_, and_CC then_RB air_VB dried_VBD for_IN
          1_CD hr_NN ._. The_DT cells_NNS were_VBD rehydrated_JJ for_IN 20_CD min_NN in_IN PBS_NNP before_IN
          blocking_VBG for_IN 20_CD min_NN with_IN diluted_VBN normal_JJ horse_NN serum_NN ._. The_DT
          cells_NNS were_VBD then_RB incubated_JJ for_IN 30_CD min_NN with_IN a_DT 1_CD :_: 200_CD
          dilution_NN of_IN monoclonal_NN antibody_NN HA_NNP ._. 11_CD (_( BAbCO_NNP ,_, Richmond_NNP ,_,
          California_NNP )_) which_WDT recognizes_VBZ the_DT influenza_NN hemagglutinin_NN
          epitope_NN YPYDVPDYA_NNP ._. The_DT cells_NNS were_VBD then_RB washed_VBN 4_CD times_NNS PBS_NNP
          and_CC incubated_JJ with_IN biotinylated_JJ secondary_JJ antibody_NN for_IN 30_CD
          min_NN at_IN room_NN temperature_NN ._. Following_VBG 4_CD rinses_NNS with_IN PBS_NNP ,_, the_DT
          cells_NNS were_VBD then_RB incubated_JJ for_IN 30_CD min_NN at_IN room_NN temperature_NN
          with_IN avidin-biotin-peroxidase_JJ complexes_NNS ._. The_DT cells_NNS were_VBD
          rinsed_JJ again_RB in_IN PBS_NNP 4_CD times_NNS ._. Diaminobenzidine_NNP (_( DAB_NNP
          substrate_NN kit_NN for_IN peroxidase_NN ,_, Vector_NNP Laboratories_NNPS ,_,
          Burlingame_NNP ,_, CA_NNP )_) was_VBD used_VBN as_IN the_DT final_JJ chromogen_NN ._. The_DT
          cells_NNS were_VBD incubated_JJ with_IN this_DT compound_NN for_IN 8_CD min_NN ._.
          Hematoxylin_NNP was_VBD used_VBN as_IN the_DT nuclear_JJ counterstain_NN ._.
          Following_VBG dehydration_NN in_IN ethanol_NN and_CC air_NN drying_VBG ,_, the_DT cell_NN
          monolayers_NNS were_VBD flooded_VBN with_IN glycerol_NN for_IN subsequent_JJ
          observation_NN ,_, photography_NN ,_, and_CC storage_NN ._.
        
        
          Phosphorylase_NNP Phosphatase_NNP Activity_NN of_IN
          Immunocomplexed_NNP 6_CD His-_NNP HA-PP_NNP 1_CD α_NN
          Phosphorylase_NNP phosphatase_NN activity_NN was_VBD measured_VBN as_IN the_DT
          release_NN of_IN trichloroacetic_JJ acid_NN (_( TCA_NNP )_) soluble_JJ counts_NNS from_IN
          32_CD P-_NNP phosphorylase_NN 
          a_DT according_VBG to_TO Cohen_NNP et_CC ._. al_NN ._. [_NN 38_CD ]_NN
          Briefly_NNP ,_, radiolabeled_JJ phosphorylase_NN 
          a_DT was_VBD synthesized_JJ by_IN taking_VBG
          phosphorylase_NN b_SYM (_( Sigma_NNP )_) ,_, at_IN a_DT concentration_NN of_IN 10_CD mg_NN /_NN ml_NN ,_,
          and_CC incubating_VBG with_IN 0_CD ._. 2_CD mg_NN /_NN ml_NN phosphorylase_NN kinase_NN
          (_( Sigma_NNP )_) for_IN 1_CD ._. 5_CD hours_NNS at_IN 30_CD °_NN C_NNP in_IN kinase_NN reaction_NN buffer_NN
          (_( 100_CD mM_NN Tris-_NNP HCl_NNP ;_: 100_CD mM_NN sodium_NN glycerol-_NN 1_CD -_: phosphate_NN ,_, pH_NN
          8_CD ._. 2_CD ;_: 0_CD ._. 1_CD mM_NN CaCl_NNP 
          2_CD ,_, 10_CD mM_NN magnesium_NN acetate_NN ,_, and_CC 0_CD ._. 2_CD
          mM_NN [_NN g-_NN 32_CD P_NN ]_NN ATP_NNP {_( 10_CD 6_CD cpm_NN /_NN nmol_NN }_) )_) ._. Enzyme_NNP samples_NNS were_VBD
          immunocomplexed_JJ 6_CD His-_NNP HA-PP_NNP 1_CD α_NN ._.
        
        
          Preparation_NNP of_IN [_NN 32_CD P_NN ]_NN pRB_NN substrate_NN and_CC pRB-directed_JJ
          phosphatase_NN activity_NN assays_NNS
          To_TO assay_NN pRB-directed_JJ phosphatase_NN activity_NN ,_, [_NN
          32_CD P_NN ]_NN -_: labeled_VBN pRB_NN substrate_NN was_VBD prepared_VBN by_IN
          immunoprecipitation_NN with_IN monoclonal_NN antibody_NN to_TO pRB_NN ,_,
          PMG_NNP 3_CD -_: 245_CD (_( PharMingen_NNP )_) ,_, from_IN [_NN 32_CD P_NN ]_NN -_: labeled_VBN CV-_NNP 1_CD P_NN cells_NNS as_IN
          described_VBN previously_RB [_NN 20_CD ]_NN ._. For_IN the_DT source_NN of_IN enzyme_NN ,_,
          immunocomplexed_JJ 6_CD His-_NNP HA-PP_NNP 1_CD α_NN from_IN induced_VBN LLWO_NNP 2_CD F_NN cells_NNS
          were_VBD mixed_JJ and_CC incubated_JJ with_IN [_NN 32_CD P_NN ]_NN -_: labeled_VBN
          immunoprecipitated_JJ pRB_NN for_IN 30_CD minutes_NNS at_IN 30_CD °_NN C_NNP as_RB
          previously_RB described_VBD [_NN 20_CD ]_NN ._. Phosphatase_NNP reactions_NNS were_VBD
          terminated_VBN by_IN the_DT addition_NN of_IN SDS-PAGE_NNP sample_NN buffer_NN and_CC
          boiling_VBG ._. Proteins_NNPS were_VBD separated_JJ on_IN SDS-polyacrylamide_NNP
          gels_NNS ._. Gels_NNP were_VBD fixed_VBN ,_, dried_VBD subjected_VBN to_TO
          autoradiography_NN ._.
        
        
          Type_NNP 1_CD Phosphatase_NNP Activity_NN of_IN Whole-_NNP Cell_NNP
          Lysates_NNP
          PP_NNP 1_CD was_VBD assayed_JJ by_IN the_DT release_NN of_IN [_NN 32_CD P_NN ]_NN H_NNP 
          3_CD PO_NNP 
          4_CD from_IN [_NN 32_CD P_NN ]_NN -_: rabbit_NN muscle_NN
          phosphorylase_NN 
          a_DT (_( 1_CD -_: 2_CD ×_NN 10_CD 5_CD cpm_NN /_NN nmol_NN )_) ._. 5_LS nM_NN
          okadaic_JJ acid_NN was_VBD used_VBN to_TO inhibit_VB PP_NNP 2_CD A_DT during_IN the_DT assay_NN ._. 1_LS
          unit_NN of_IN PP_NNP 1_CD activity_NN releases_NNS 1_CD nmol_NN of_IN Pi_NNP /_NN min_NN at_IN
          30_CD °_NN C_NNP ._.
        
        
          Immunoprecipitation_NNP using_VBG PP_NNP 1_CD Isoform-specific_NNP
          antibody_NN
          LLWO_NNP 2_CD F_NN cell_NN extracts_NNS (_( 50_CD ug_NN )_) were_VBD immunoprecipitated_JJ
          with_IN approximately_RB 1_CD ug_NN of_IN isoform-specific_JJ rabbit_NN
          antiserum_NN to_TO PP_NNP 1_CD α_NN as_RB previously_RB described_VBD [_NN 38_CD ]_NN ._.
          Immunoprecipitation_NNP with_IN 1_CD ug_NN of_IN normal_JJ rabbit_NN serum_NN
          served_VBD as_IN a_DT negative_JJ control_NN ._.
        
        
          GST-PNUTS_NNP Affinity_NNP Chromatography_NNP
          Induction_NNP of_IN GST-PNUTS_NNP fusion_NN protein_NN synthesis_NN and_CC
          isolation_NN by_IN affinity_NN chromatography_NN using_VBG
          glutathione-_NN Sepharose_NNP beads_NNS (_( Pharmacia_NNP )_) was_VBD performed_VBN as_IN
          described_VBN previously_RB [_NN 32_CD ]_NN ._. Induced_NNP LLWO_NNP 2_CD F_NN cell_NN
          extracts_NNS were_VBD then_RB incubated_JJ for_IN 1_CD hour_NN at_IN 4_CD °_NN C_NNP with_IN
          recombinant_JJ GST_NNP or_CC GST-PNUTS_NNP fusion_NN protein_NN bound_VBN to_TO
          glutathione-_NN Sepharose_NNP ._. Bound_NNP proteins_NNS were_VBD washed_VBN with_IN
          PBS_NNP ,_, separated_JJ on_IN 10_CD %_NN SDS-polyacrylamide_NNP gels_NNS ,_, and_CC
          transferred_VBD to_TO nitrocellulose_NN ._. Protein_NNP blots_NNS were_VBD then_RB
          developed_VBN using_VBG antibody_NN to_TO hemagglutinin_NN for_IN
          6_CD His-_NNP HA-PP_NNP 1_CD α_NN detection_NN ._.
        
        
          Polysome_NNP isolation_NN
          Uninduced_NNP and_CC induced_VBN LLWO_NNP 2_CD F_NN cells_NNS (_( 10_CD ×_NN 100_CD mm_NN
          dishes_NNS )_) were_VBD washed_VBN 3_CD -_: times_NNS with_IN ice-cold_JJ serum-free_JJ DMEM_NNP
          containing_VBG 10_CD ug_NN /_NN ml_NN cycloheximide_NN ._. After_IN the_DT last_JJ wash_NN ,_,
          cells_NNS were_VBD scraped_JJ into_IN a_DT final_JJ volume_NN of_IN 5_CD ml_NN of_IN this_DT
          same_JJ medium_NN for_IN each_DT 10_CD -_: dish_NN treatment_NN ._. The_DT cells_NNS were_VBD
          harvested_VBN with_IN a_DT brief_JJ centrifugation_NN ._. The_DT cell_NN pellet_NN
          was_VBD resuspended_JJ in_IN 0_CD ._. 5_CD ml_NN lysis_NNS buffer_NN (_( 125_CD mM_NN KCl_NNP ,_, 12_CD ._. 5_LS
          mM_NN mgCl_NN 2_CD ,_, 10_CD mM_NN Hepes_NNP ,_, pH_NN 6_CD ._. 8_CD ,_, 0_CD ._. 1_CD mM_NN dithiothreitol_NN ,_, 10_CD
          ug_NN /_NN ml_NN cycloheximide_NN ,_, 0_CD ._. 5_CD %_NN Triton_NNP X-_NNP 100_CD ,_, 0_CD ._. 5_CD %_NN
          deoxycholate_NN )_) followed_VBN by_IN 10_CD passages_NNS through_IN a_DT 22_CD gauge_NN
          needle_NN to_TO lyse_NN the_DT cells_NNS ._. The_DT resulting_VBG extracts_NNS were_VBD
          then_RB layered_JJ on_IN the_DT top_NN of_IN a_DT 10_CD -_: 40_CD %_NN sucrose_NN gradient_NN (_( 125_CD
          mM_NN KCl_NNP ,_, 12_CD ._. 5_LS mM_NN mgCl_NN 2_CD ,_, 10_CD mM_NN Hepes_NNP ,_, pH_NN 6_CD ._. 8_CD ,_, 0_CD ._. 1_CD mM_NN
          dithiothreitol_NN ,_, 10_CD ug_NN /_NN ml_NN cycloheximide_NN )_) and_CC centrifuged_JJ
          at_IN 4_CD °_NN C_NNP in_IN a_DT SW_NNP 50_CD ._. 1_LS rotor_NN at_IN 48_CD ,_, 000_CD rpm_NN for_IN 60_CD min_NN ._. After_IN
          centrifugation_NN ,_, the_DT gradient_NN was_VBD fractionated_JJ in_IN 200_CD ul_NN
          aliquots_NNS and_CC analyzed_VBD at_IN A_DT 
          260_CD using_VBG a_DT Bio-_NNP Rad_NNP SmartSpec_NNP 3000_CD ._. A_DT
          single_JJ peak_NN of_IN A_DT 
          260_CD absorbance_NN in_IN the_DT bottom_JJ portion_NN
          of_IN the_DT gradient_NN was_VBD analyzed_VBN as_IN polysome_NN fraction_NN ._.
        
        
          RT-PCR_NNP analyses_NNS of_IN PP_NNP 1_CD α_NN mRNA_NN
          LLWO_NNP 2_CD F_NN cells_NNS were_VBD induced_VBN with_IN doxycycline_NN (_( 2_CD ug_NN /_NN ml_NN )_)
          for_IN 24_CD hr_NN ._. Negative_JJ control_NN LLWO_NNP 2_CD F_NN cells_NNS were_VBD not_RB induced_VBN
          with_IN doxycycline_NN ._. For_IN total_JJ RNA_NNP experiments_NNS ,_, RNA_NNP was_VBD
          harvested_VBN from_IN monolayered_JJ cells_NNS using_VBG QIAshredder_NNP and_CC
          Qiagen_NNP RNeasy_NNP mini-kit_JJ ._. Polysome_NNP RNA_NNP was_VBD recovered_VBN from_IN
          polysome_NN fractions_NNS by_IN first_JJ diluting_VBG fractions_NNS in_IN 3_CD ._. 5_CD
          volumes_NNS of_IN lysis_NNS buffer_NN from_IN the_DT Qiagen_NNP RNeasy_NNP mini-kit_JJ
          and_CC then_RB continuing_VBG with_IN the_DT manufacturer_NN 's_POS instructions_NNS ._.
          RNA_NNP was_VBD quantitated_JJ by_IN UV_NNP spectrometry_NN ._. 1_LS ug_NN total_JJ RNA_NNP
          (_( or_CC 200_CD ng_NN polysome_NN RNA_NNP )_) was_VBD used_VBN in_IN first_JJ strand_NN cDNA_NN
          synthesis_NN using_VBG SUPERSCRIPT_NNP II_NNP reverse_VB transcriptase_NN
          (_( Life_NNP Technologies_NNPS )_) following_VBG manufacturer_NN 's_POS
          instructions_NNS ._. cDNA_NN was_VBD extracted_VBN by_IN one_CD phenol_NN
          chloroform_NN :_: isoamyl_NN alcohol_NN extraction_NN followed_VBN by_IN one_CD
          chloroform_NN isoamyl_NN alcohol_NN extraction_NN and_CC then_RB ethanol_NN
          precipitated_VBD ._. cDNA_NN was_VBD resuspended_JJ in_IN 20_CD ul_NN water_NN and_CC
          used_VBN in_IN a_DT 30_CD -_: cycle_NN PCR_NNP reaction_NN with_IN 1_CD uM_NN of_IN each_DT of_IN the_DT
          following_VBG four_CD primers_NNS :_: {_( CCACGCTGTTTTGACCTCCATAGAAGACAC_NNP ,_,
          CACATAGTCCCCCAGAAAGAGGTAGTTGCT_NNP }_) ,_, in_IN which_WDT product_NN only_RB
          forms_VBZ from_IN 6_CD His-_NNP HA-PP_NNP 1_CD α_NN cDNA_NN ,_, and_CC
          {_( GACGCGGGCAAGCAGTCCCTCGAGACCATTGCCTGCTG_NNP ,_,
          CTGGAGACCCACGACCTGGCCTGCCGTTG_NNP }_) ,_, in_IN which_WDT product_NN only_RB
          forms_VBZ from_IN endogenous_JJ PP_NNP 1_CD α_NN cDNA_NN ._. Reaction_NNP also_RB contained_VBD
          200_CD uM_NN dNTPs_NNS ,_, 1_CD mM_NN Mg_NNP +_NN +_NN ,_, and_CC 5_CD units_NNS Taq_NNP DNA_NNP polymerase_NN
          (_( Life_NNP Technologies_NNPS )_) with_IN supplied_VBN reaction_NN buffer_NN ._. 2_LS ul_NN
          of_IN the_DT PCR_NNP product_NN was_VBD loaded_VBN onto_IN a_DT 1_CD %_NN agarose_NN gel_NN
          containing_VBG ethidium_NN bromide_NN for_IN UV_NNP visualization_NN ._.
        
      
      
        Authors_NNP '_'' Contributions_NNP
        JER_NNP ,_, JWL_NNP ,_, and_CC EMM_NNP conceived_VBD the_DT study_NN and_CC participated_VBD
        in_IN its_PRP$ design_NN and_CC execution_NN ._. MPS_NNP participated_VBD in_IN plasmid_NN
        constructions_NNS ._. PK_NNP performed_VBD RT-PCR_NNP and_CC polysome_NN analysis_NN ._.
        EV-M_NNP provided_VBD PP_NNP 1_CD -_: isoform_NN specific_JJ antibodies_NNS and_CC
        participated_VBD in_IN PP_NNP 1_CD immunoprecipitations_NNS and_CC western_JJ blots_NNS ._.
        Authors_NNP read_VBD and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
